/
COSM
$0.18+$0.00 (+1.63%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$10.7M
62M shares
52-week range
$0.16 – $1.32
1% from low
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
NASDAQ
CS
Borrow rate
6.73%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-84.08
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.1M | $39.7M | $55.4M | $56.2M | $50.3M | $53.4M | $54.4M | $65.3M |
| Cost of revenue | $34.7M | $36.0M | $47.3M | $47.9M | $44.4M | $49.0M | $50.1M | $57.4M |
| Gross profit | $2.4M | $3.7M | $8.1M | $8.3M | $6.0M | $4.3M | $4.3M | $7.9M |
| Gross margin | 6.5% | 9.2% | 14.5% | 14.8% | 11.8% | 8.1% | 7.9% | 12.1% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $533.3K | $519.4K |
| Operating income | −$1.2M | −$255.8K | $2.7M | −$4.5M | −$7.5M | −$21.8M | −$15.5M | −$16.5M |
| EBITDA | −$2.2M | −$988.6K | $4.4M | −$3.8M | −$8.9M | −$17.1M | −$13.9M | −$15.2M |
| Net income | −$9.1M | −$3.3M | $820.8K | −$8.0M | −$13.8M | −$18.5M | −$16.2M | −$19.1M |
| Net margin | -24.4% | -8.3% | 1.5% | -14.2% | -27.5% | -34.7% | -29.7% | -29.3% |
| EPS (diluted) | -17.02 | -6.21 | 1.54 | -23.74 | -33.16 | -2.15 | -1.17 | -0.63 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $87M | $0.01 | $0.01–$0.01 | 1 |
| 2027 | $111M | $0.07 | $0.07–$0.07 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Cosmos Holdings Inc. Common Stock
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
www.cosmoshealthinc.com- Employees
- 163
- IPO / List date
- May 19, 2010
- HQ
- THESSALONIKI, J3
Held by traders on TradeandTell
No one on the platform currently holds COSM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 390,500 | $123.9K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2022-12-16 | 1-for-25reverse |
| 2017-11-21 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded COSM yet.
